---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-104347"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:28:51.347630+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Allurion cuts ~65% workforce, reports preliminary Q2 revenue ~$3M, shifts to GLP-1 combo therapy

## Summary
- Preliminary Q2 2025 revenue ~$3M, operating loss ~$7M, improved from $9.3M loss in Q2 2024; operating expenses down ~50% YoY.
- Restructuring: workforce reduction of ~70 employees (~65% of total); estimated severance charges of ~$1.5M; completion expected by end of Q3 2025.
- Signed term sheet with strategic partner for ex-US distribution and potential joint development of a GLP-1 drug-eluting intragastric balloon.
- Submitted protocol to IRBs for prospective study on low-dose GLP-1 + Allurion Program for weight loss and muscle preservation; enrollment expected in 2025.
- PMA application for Allurion Balloon accepted by FDA for evaluation.

## SEC filing metadata
- accession: 0000950170-25-104347
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 2.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000095017025104347/0000950170-25-104347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000095017025104347/alur-20250804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-104347
- JSON: https://secwatch.observer/filing/0000950170-25-104347.json
- Plain text: https://secwatch.observer/filing/0000950170-25-104347.txt

## Key facts
- Restructurings & Charges
  ALLURION TECHNOLOGIES, INC. announced a restructuring with charges of approximately $1.5 million (approximately 70 employees, or approximately 65% of its workforce).
  - Type: restructuring
  - Charge: approximately $1.5 million
  - Headcount: approximately 70 employees, or approximately 65% of its workforce
  source text: employees between August 4, 2025 and August 6, 2025. As part of this Restructuring Plan, the Company expects to incur severance and severance-related charges of approximately $1.5 million. The Company’s estimated restructuring charges is based on a number of assumptions. Actual results may differ materially and the Company may also incur other charges or cash
  evidence_url: https://www.sec.gov/Archives/edgar/data/1964979/000095017025104347/0000950170-25-104347-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.